[…] considered after consultation with medical microbiologists or infection control practitioners (ICPs) in the facility Check with your local laboratory to confirm the correct way they would like requisitions labelled for screening swabs. This may include wording such as: "Carbapenemase Producing Organism Search". Isolates suspected of harboring a CPO gene should be sent to the BC Public Health Reference Microbiology Laboratory (BCPHRML)...
Type: Media
Infection in Home Health Care – Prevalence, Risk Factors, and Challenges Jingjing Shang, PhD, RN, OCN Assistant Professor Columbia University, School of Nursing Hosted by Paul Webber paul@webbertraining.com www.webbertraining.com January 22, 2015 Objectives Review the literature on infection in home care setting Understand the prevalence and risk factors of infection in home care Discuss the challenges in developing infection surveillance <mark...
Type: Media
2/27/2015 1 Patient Hand Hygiene: The Next Frontier Jocelyn Srigley, MD, MSc, FRCPC March 5, 2015 Disclosures •No conflicts of interest •Salary support from the AMMI Canada/Astellas Post- Residency Fellowship •Project supported by grants from Canada Health If d th H lth T h l g E h g b Infoway an d th e Health T echnology Exchange; by Infonaut, Inc.; and by...
Type: Media
Prevention of Clostridium difficile Infection - What We Find in Guidelines Hosted by Paul Webber paul@webbertraining.com www.webbertraining.com March 26, 2015 Dr. Walter Zingg, MD Dr. Maria Martin, MD, MPH Outline PROHIBIT work package 2 Guidelines in WP 2 C. difficile Studies and guidelines Treatment Summary 2 PROHIBIT WP2 Identification and analysis of current guidelines for prevention of HAI (CDI, VAP, CABSI, SSI, UTI) in European countries...
Type: Media
THE PSYCHOLOGY OF HAND HYGIENE: HOW TO IMPROVE HAND HYGIENE USING BEHAVIOUR CHANGE FRAMEWORKSJocelyn Srigley, MD, MSc, FRCPCMedical Microbiologist, BC Children’s & Women’s Hospitals, Vancouver, BCDirector, Infection Prevention & Control, Provincial Health Services Authority@Jocelyn Srigleywww.webbertraining.comJuly 13, 2017Hosted by Paul Webberpaul@webbertraining.com Disclosures•No conflicts of interest2 Objectives•Describe the psychological frameworks/theories that have been used to predict hand hygiene compliance, including motivators and barriers of hand hygiene•Review...
Type: Media
Module 1: Introduction Orientation Program for Infection Control Professionals C o n t e n t s Module 1: Introduction and Four -Week Schedule ...
Type: Media
[…] article: Mistry R, Russell RV, Walker N, Ofo E. The single-userhinolaryngoscope: an evaluation and costcomparison. J Laryngol Otol 2020; 134 : 790 –797. https://doi.org/10.1017/ S0022215120001656 Accepted: 29 April 2020First published online: 28 September 2020 Key words:Endoscopy; Otolaryngology;Costs And Cost Analysis Author for correspondence:Dr Rakesh Mistry,Department of Otolaryngology,St George ’s University Hospital, Blackshaw Road, London, SW17 0QT, UKE-mail: rakeshmistry@nhs.net Fax: +450 72 25 20 50 ©TheAuthor(s),2020.PublishedbyCambridge...
Type: Media
[…] -480. 3 PLoS One . 2022 Mar 10;17(3):e0265076. 4 BDJ Open . 2021 Mar 24;7(1):15. doi: 10.1038/s41405 -021 -00070 -9 AGMP Decisions (Summary Paragraphs) on Procedure Page 1 of 1 Decision Summary: Dental Ultrasonic Scal ing The B.C. AGMP Expert Committee reviewed whether Dental Ultrasonic Scaling are aerosol generating medical procedure s (AGMP s). In conjunction with the UBC Therapeutics I nitiative group, <mark...
Type: Media
AGMP Decisions (Summary Paragraphs) on Procedure Page 1 of 2 Decision Summary: Vibrat ing-Mesh Nebulizers The B.C. AGMP Expert Committee reviewed whether Vibrating-m esh nebulizers are aerosol generating . The AGMP Expert Committee conducted a literature review to identify relevant primary evidence, review articles, and guidelines/recommendations from governing bodies, medical societies and other expert groups. The search results were assessed for evidence q uality and source...
Type: Media
Measles, Mumps, Rubella and Varicella (MMRV) Vaccine Questions and Answ ers for Immunization Providers – December 2013 1. When was the MMRV vaccine authorized for use? 2. What is the intended use of MMRV vaccine in BC? 3. Who may receive the MMRV vaccine before July 2014? 4. What does the MMRV vaccine packaging look like? 5. How is the MMRV vaccine supplied? 6....
Type: Media
1 Quadrivalent Influenza Vaccine (QIV) Fact Sheet – 2014/15 1. What are quadrivalent influenza vaccine s? 2. Are quadrivalent influenza vaccine s recommended over trivalent influenza vaccine s, and will these be available in the publicly funded program in 2014/ 15? 3. Which quadrivalent influenza products are authorized for use in Canada , and which will be available for the...
Type: Media
Module 5: Surveillance Orientation Program for Infection Control Pr ofessionals Orientation Program for Infection Control Professionals ICP Orientation Program Page i Table of Contents Module 5: Surveillance ...
Type: Media
Methicillin -Resistant Staphylococcus aureus (MRSA) Surveillance Report For the Fiscal Year 201 3/20 14 (April 1, 201 3 to March 31, 201 4) Prepared by: Provincial Infection Control Network of British Columbia (PICNet) September 201 4 Provincial Infection Control Network of BC (PICNet) 1001 West Broadway, Suite 504 Vancouver, BC, V6H 4B1 www.picnet.ca Fax: 604 -875 -4373 Tel: 604 -875 -4844 ext 22983 Email: picnet@phsa.ca Disclaim er...
Type: Media
British Columbia Prov incial Nursing Skin and Wound Committee Guideline: Wound Bed Preparat ion for Healable and Non Healable Wounds Note: This is a controlled document. A printed copy may not reflect the current, electronic version on the CLWK website. Any document appearing in paper form should always be checked against the electronic version prior to use; the electronic version is always the...
Type: Media
Healthcare -associated infections surveillance report Carbapenem ase -producing organisms (CPO) update January 201 7 Highlights for Q 1 and Q2 20 16/1 7 (April 1 – September 8 , 201 6) 43 new cases of CPO were identified amon g 39 patients in BC acute care facilities NDM was the most common gene identified (29 /43 cases, 67.4 %) 31 cases (72.1 %) reported...
Type: Media
Healthcare -associated infections surveillance report Carbapenem ase -producing organisms (CPO) update March 201 7 Highlights for Q 3 20 16/1 7 (September 9 – December 1 , 201 6) 12 new cases of CPO were identified amon g 11 patients in BC acute care facilities NDM was the most common gene identified (10 /12 cases, 83.3 %) 8 cases (66.7 %) reported healthcare exposure...
Type: Media
Healthcare -associated infections surveillance report Carbapenem ase -producing organisms (CPO s) update November 201 7 Highlights for Q 1 20 17/1 8 (April 1 – June 16 , 2017 ) 40 new cases of CPO were identified among 35 patients in BC acute care facilities NDM was the most common gene identified (27 /40 cases, 67.5 %) 31 cases (77.5%) reported healthcare exposure outside...
Type: Media
Healthcare -associated infections surveillance report Carbapenem ase -producing organisms (CPO s) update January 2018 Highlights for Q 2 20 17/1 8 (June 1 6 – September 7, 2017 ) 28 new cases of CPO were identified in 2 5 patients in BC acute care facilities . The majority of new cases harbored the NDM resistance gene (20 , 7 1.4%) . 14...
Type: Media
Healthcare -associated infections surveillance report Carbapenem ase -producing organisms (CPO s) update March 2018 Highlights for Q 3 20 17/1 8 (September 8 – November 30 , 2017 ) 11 new cases of CPO were identified in 11 patients in BC acute care facilities . The NDM resistance gene accounted for the majority of cases (8, 72.7 %) . 4 cases (36.4...
Type: Media
Healthcare -associated infections surveillance report Carbapenem ase -Producing O rganisms (CPO s) U pdate August 2018 Highlights for Q 4 20 17/1 8 (Dec 1, 2017 – March 31, 2018 ) 52 new cases of CPO were identified among 51 patients . 2 cases were reported in community healthcare setting s, including the first CPO case identified in the region of Northern Health. ...
Type: Media